1. Home
  2. |Insights
  3. |CPSC Announces September 4th Public Meeting to Discuss Reform Legislation

CPSC Announces September 4th Public Meeting to Discuss Reform Legislation

Client Alert | 1 min read | 08.18.08

The U.S. Consumer Product Safety Commission (CPSC) will hold a public meeting on Thursday, September 4, 2008, entitled "An Overview of the Consumer Safety Improvement Act of 2008." The purpose of this meeting is to address major provisions and implementation of the Consumer Product Safety Improvement Act of 2008, which calls for broad reform in the regulation of consumer product safety and the operations of the CPSC. The Act was signed into law by President Bush on Thursday, August 14, 2008.

Acting Chairman Nancy Nord and Commissioner Thomas H. Moore will provide opening remarks to meeting attendees, which will be followed by discussions by the CPSC staff of the following topics:

  • Implementation of the Act and public communications;
  • Provisions of general applicability contained in the Act; and
  • Children's product-specific provisions contained in the Act.

The meeting will conclude with a question and answer session followed by closing remarks.

The meeting will take place on Thursday, September 4, 2008 from 9:30 a.m. to 4:30 p.m. at the U.S. Department of Commerce, Herbert C. Hoover Building Auditorium, 1401 Constitution Avenue, NW, Washington, D.C., 20230. Registration is free and open to the public. 

Crowell & Moring attorneys will be in attendance at the meeting and will thereafter issue a summary of the CPSC's position regarding the new Act.

Insights

Client Alert | 6 min read | 04.29.26

CMS Seeks to Expand Interoperability Requirements to Drug Pre-Authorization (FAQ)

On April 10, 2026, the Centers for Medicare and Medicaid Services (CMS) issued a proposed rule (2026 CMS Interoperability Standards and Prior Authorization for Drugs, or CMS-0062-P) outlining the agency’s plans to impose new interoperability requirements on payors participating in certain Medicare and Medicaid programs. As described by the agency in a recent press release, the proposed rule “builds on” prior rulemaking by clarifying and enhancing interoperability requirements for payors’ prior authorization processes, specifically those associated with coverage requests for pharmaceutical therapies....